These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9396398)

  • 21. Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma.
    Cvejic D; Savin S; Petrovic I; Selemetjev S; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2005 Sep; 27(3):210-4. PubMed ID: 16244583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults.
    Fenton C; Patel A; Dinauer C; Robie DK; Tuttle RM; Francis GL
    Thyroid; 2000 Apr; 10(4):349-57. PubMed ID: 10807064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.
    Renaud F; Gnemmi V; Devos P; Aubert S; Crépin M; Coppin L; Ramdane N; Bouchindhomme B; d'Herbomez M; Van Seuningen I; Do Cao C; Pattou F; Carnaille B; Pigny P; Wémeau JL; Leteurtre E
    Thyroid; 2014 Sep; 24(9):1375-84. PubMed ID: 25012490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
    Mishra A; Agrawal V; Krishnani N; Mishra SK
    J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
    Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
    Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.
    Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV
    Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlated expression of BCL-2 protein, estrogen receptor, cathepsin D and low growth fraction (PCNA) in intracystic papillary breast carcinoma.
    Lanzafame S; Emmanuele C; Torrisi A; Magro G
    Pathol Res Pract; 1998; 194(8):541-7. PubMed ID: 9779488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
    Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort.
    Londero SC; Krogdahl A; Bastholt L; Overgaard J; Pedersen HB; Hahn CH; Bentzen J; Schytte S; Christiansen P; Gerke O; Godballe C;
    Thyroid; 2015 Jan; 25(1):78-84. PubMed ID: 25368981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
    Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
    Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
    Xu YJ
    Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
    J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
    Nakano S; Kawamura J
    Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence.
    Palmer BA; Zarroug AE; Poley RN; Kollars JP; Moir CR
    J Pediatr Surg; 2005 Aug; 40(8):1284-8. PubMed ID: 16080933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma.
    Uruno T; Miyauchi A; Shimizu K; Nakano K; Takamura Y; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K
    Surg Today; 2004; 34(11):891-5. PubMed ID: 15526121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
    Kim WY; Kim HY; Son GS; Bae JW; Lee JB
    J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors.
    Minguillon C; Schönborn I; Reles A; Bartel U; Lichtenegger W
    Gen Diagn Pathol; 1996 Mar; 141(3-4):197-201. PubMed ID: 8705783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.